Unilever Posts 3.8% Underlying Sales Growth, But Valuation Concerns Persist

What happened

Unilever reported underlying sales growth of 3.8% in its latest quarter, driven by volume and price gains amid its largest portfolio restructuring in decades. The result aligns with management's 3-5% medium-term guidance and follows a 3% print in Q1 2025. However, the growth rate remains modest for a company trading at ~32x trailing earnings, nearly 40% above a DCF-based intrinsic value estimate of ~$43 per share. Execution risks around the Ice Cream demerger and €800m productivity programme continue to cloud the outlook, with the stock having delivered virtually no total return over the past five years. The improvement does not materially alter the risk-reward calculus; the premium valuation still leaves little room for error.

Implication

The 3.8% underlying sales growth is reassuring but does not change the fundamental valuation picture: Unilever still trades at a 32x P/E with a DCF value roughly 39% below market price. While the company's defensive brand portfolio generates robust cash flow, the margin of safety is minimal given the execution complexities of the ongoing transformation. For existing holders, this quarter provides no compelling reason to add exposure; for new investors, waiting for a pullback toward the high-$40s or low-$50s would offer a better risk/reward. The Ice Cream demerger and cost savings rollout remain key swing factors to monitor. Until valuation resets or growth accelerates sustainably, the stock remains a hold at best.

Thesis delta

The 3.8% underlying sales growth is in line with expectations and does not invalidate the cautious thesis. The rich valuation persists, and the transformation risks are unchanged. No shift in opinion; maintain potential sell stance.